Community-reported Mirtazapine side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Mirtazapine Side Effect Episode
Have You dealt with a Mirtazapine side effect? Share your experience
Review Mirtazapine Safety Reports submitted to FDA
Total Mirtazapine reports: 574.Mirtazapine FDA safety alerts: 2003 2004 2005 .
Reported deaths: 99 Reported hospitalizations: 168.
Take Mirtazapine Side Effects Survey, Discuss Mirtazapine with others
FDA Reported Mirtazapine Side Effects: completed suicide, confusional state, pain in extremity, weight increased, suicidal ideation, agitation, depression, loss of consciousness, hyponatraemia, myalgia, restless legs syndrome.
Mirtazapine Usage.
If you have questions about Mirtazapine, you can ask a Health Expert or Ask Patient Community about Mirtazapine.
< Previous Showing 201-300 of 574 Next >
Mirtazapine Side Effects Report #5322053-9Consumer or non-health professional from SWITZERLAND reported MIRTAZAPINE problem on Apr 27, 2007. Female patient, 73 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aggression, disorientation, paranoia, restlessness. MIRTAZAPINE dosage: unknown. During the same period patient was treated with MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5322065-5
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 25, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: 30 MG. During the same period patient was treated with DULOXETINE, TEMAZEPAM. Patient died.
Mirtazapine Side Effects Report #5323095-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Feb 09, 2007. Female patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anorexia, fear, gait disturbance, muscular weakness, peripheral coldness, suicidal ideation. MIRTAZAPINE dosage: 15 MG; QD; PO. During the same period patient was treated with ATENOLOL, DULOXETINE. Patient recovered.
Mirtazapine Side Effects Report #5323097-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 26, 2007. Female patient, 54 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, weight increased. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, TETRABENAZINE, QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5323748-3
Physician from UNITED KINGDOM reported MIRTAZAPINE problem on May 04, 2007. Male patient, 60 years of age, was diagnosed with depression, schizophrenia, anxiety and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction, prescribed overdose, skin discolouration. MIRTAZAPINE dosage: 30 MG, DAILY (1/D). During the same period patient was treated with ZYPREXA, DIAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5324167-6
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 25, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with DULOXETINE HYDROCHLORIDE)DULOXETINE HYDROCHLORIDE), TEMAZEPAM. Patient died on 02/04/2007.
Mirtazapine Side Effects Report #5324216-5
Health Professional from UNITED KINGDOM reported MIRTAZAPINE problem on Apr 25, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: 30 MG; QD; PO. During the same period patient was treated with DULOXETINE, TEMAZEPAM. Patient died.
Mirtazapine Side Effects Report #5324341-9
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 03, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: 30 MG; ORAL. During the same period patient was treated with DULOXETINE, TEMAZEPAM. Patient died.
Mirtazapine Side Effects Report #5325334-8
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Apr 26, 2007. Female patient, 54 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, exercise lack of, incorrect dose administered, treatment noncompliance, weight increased. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LITHIUM CARBONATE, QUETIAPINE FUMARATE, TETRABENAZINE. Patient recovered.
Mirtazapine Side Effects Report #5325771-1
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 04, 2007. Male patient, 41 years of age, was diagnosed with anxiety, depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: adjustment disorder, depression, intentional self-injury, neck injury, paranoia, partner stress, personality disorder. MIRTAZAPINE dosage: DF/45 MG ORAL. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5325783-8
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Apr 26, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: (30 MG), ORAL. During the same period patient was treated with DULOXETINE. Patient died.
Mirtazapine Side Effects Report #5325785-1
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 26, 2007. Female patient, 54 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus inadequate control, exercise lack of, treatment noncompliance, weight increased. MIRTAZAPINE dosage: 90 MG (90 MG, 1 IN 1 D), ORAL. Patient recovered.
Mirtazapine Side Effects Report #5326871-2
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on May 07, 2007. Male patient, 34 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: coma, confusional state, decreased interest, dialysis, disturbance in attention, factor v deficiency, impaired work ability, memory impairment, pulmonary embolism. MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with ANCACAPS. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5328182-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from NETHERLANDS on Apr 20, 2007. Female patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. MIRTAZAPINE dosage: unknown. Patient recovered.
Mirtazapine Side Effects Report #5330494-9
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on May 04, 2007. Female patient, 54 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, glutamate dehydrogenase increased. MIRTAZAPINE dosage: unknown. During the same period patient was treated with VENLAFAXIINE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5330516-5
MIRTAZAPINE problem was reported by a Consumer or non-health professional from CANADA on May 07, 2007. Female patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: colitis, gastrooesophageal reflux disease. MIRTAZAPINE dosage: unknown. Patient recovered.
Mirtazapine Side Effects Report #5330539-6
Consumer or non-health professional from FINLAND reported MIRTAZAPINE problem on May 10, 2007. Female patient, 83 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, masked facies, musculoskeletal stiffness. MIRTAZAPINE dosage: 45 MG QD. During the same period patient was treated with SPIRONOLACTONE, METOPROLOL SUCCINATE, ENALAPRIL MALEATE, FELODIPINE, RISPERIDONE, LORAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5330554-2
MIRTAZAPINE problem was reported by a Consumer or non-health professional from NETHERLANDS on May 14, 2007. Female patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MIRTAZAPINE dosage: unknown. Patient died.
Mirtazapine Side Effects Report #5331806-2
Physician from UNITED STATES reported MIRTAZAPINE problem on May 04, 2007. Male patient, 67 years of age, was diagnosed with depression, phantom pain, osteomyelitis and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, condition aggravated, confusional state, delirium, depression, hallucination, visual, mental status changes. MIRTAZAPINE dosage: 15 MG DAILY, INCREASED. During the same period patient was treated with GABAPENTIN, LINEZOLID, INSULIN, EPOETIN, PANTOPRAZOLE. Patient recovered.
Mirtazapine Side Effects Report #5335449-6
MIRTAZAPINE problem was reported by a Consumer or non-health professional from CANADA on May 10, 2007. Male patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased. MIRTAZAPINE dosage: 45 MG QD ORAL. During the same period patient was treated with ATORVASTATIN CALCIUM. Patient recovered.
Mirtazapine Side Effects Report #5335451-4
Consumer or non-health professional from CANADA reported MIRTAZAPINE problem on May 10, 2007. Male patient, 55 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: priapism. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with TERAZOSIN HYDROCHLORIDE, PERINDOPRIL, NIFEDIPINE, BISOPROLOL FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5337140-9
MIRTAZAPINE problem was reported by a Consumer or non-health professional from FRANCE on May 10, 2007. Female patient, 37 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. MIRTAZAPINE dosage: 7.5 MG BID ORAL. During the same period patient was treated with METHADONE HYDROCHLORIDE, OXAZEPAM. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5337490-6
Consumer or non-health professional from AUSTRALIA reported MIRTAZAPINE problem on May 14, 2007. Male patient, 39 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: renal failure. MIRTAZAPINE dosage: 30 MG QD, ORAL. Patient recovered.
Mirtazapine Side Effects Report #5337491-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWEDEN on May 14, 2007. Male patient, 55 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. MIRTAZAPINE dosage: unknown. Patient recovered.
Mirtazapine Side Effects Report #5339403-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 16, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, rheumatoid arthritis. MIRTAZAPINE dosage: 45 MG;QD;PO. During the same period patient was treated with LEVOTHYROXINE, METHOTREXATE, OMEPRAZOLE, TRAMADOL. Patient recovered.
Mirtazapine Side Effects Report #5339493-4
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on May 21, 2007. Female patient, 35 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hypomania, suicide attempt. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with VENLAFAXIINE, LORAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5339498-3
Consumer or non-health professional from SWITZERLAND reported MIRTAZAPINE problem on May 21, 2007. Male patient, 69 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: haemorrhage, skin laceration, suicide attempt. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with CHLORAL HYDRATE, MAGNESIOCARD, VENLAFAXIINE, SERTRALINE, PERINDOPRIL, METOPROLOL SUCCINATE, ATORVASTATIN CALCIUM, PHENPROCOUMON. Patient recovered.
Mirtazapine Side Effects Report #5341439-X
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 16, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, rheumatoid arthritis. MIRTAZAPINE dosage: 45 MG, ORAL. During the same period patient was treated with LEVOTHYROXINE, METHOTREXATE, OMEPRAZOLE, TRAMADOL. Patient recovered.
Mirtazapine Side Effects Report #5341473-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 16, 2007. Female patient, 40 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal distension, constipation. MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, DIAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5341489-3
MIRTAZAPINE problem was reported by a Health Professional from UNITED KINGDOM on May 15, 2007. Male patient, 30 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: intentional overdose, supraventricular tachycardia. MIRTAZAPINE dosage: 600 MG,. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5341655-7
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 17, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, rheumatoid arthritis. MIRTAZAPINE dosage: 45 MG, ORAL. Patient recovered.
Mirtazapine Side Effects Report #5341657-0
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on May 24, 2007. Male patient, 75 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, skin laceration. MIRTAZAPINE dosage: 45 MG, ORAL. During the same period patient was treated with ESCITALOPRAM OXALATE, BROMAZEPAM, COSAAR PLUS, PANTOPRAZOLE, YEAST DRIED. Patient died.
Mirtazapine Side Effects Report #5341658-2
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 16, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: condition aggravated, rheumatoid arthritis. MIRTAZAPINE dosage: 45 MG, ORAL. During the same period patient was treated with LEVOTHYROXINE, METHOTREXATE, OMEPRAZOLE, TRAMADOL. Patient recovered.
Mirtazapine Side Effects Report #5341684-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 18, 2007. Male patient, 64 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. MIRTAZAPINE dosage: 45 MG; QD; PO. During the same period patient was treated with RAMIPRIL, OMEPRAZOLE, FUROSEMIDE, DOXAZOSIN MESYLATE, ATENOLOL, ADALAT, ALLOPURINOL, ATORVASTATIN CALCIUM. Patient recovered.
Mirtazapine Side Effects Report #5341767-8
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 18, 2007. Male patient, 30 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. MIRTAZAPINE dosage: 600 MG; X1; PO. During the same period patient was treated with PARACETAMOL, ALCOHOL. Patient recovered.
Mirtazapine Side Effects Report #5343406-9
MIRTAZAPINE problem was reported by a Health Professional from UNITED KINGDOM on May 17, 2007. Male patient, 64 years of age, weighting 205.0 lb, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. MIRTAZAPINE dosage: 45 MG, ORAL. During the same period patient was treated with ADALAT, ALLOPURINOL, ATENOLOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, DOXAZOSIN MESYLATE, FUROSEMIDE, GLICLAZIDE. Patient recovered.
Mirtazapine Side Effects Report #5343571-3
Physician from UNITED KINGDOM reported MIRTAZAPINE problem on May 24, 2007. Male patient, 60 years of age, was diagnosed with depression, schizophrenia, anxiety and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bundle branch block right, myocardial infarction, prescribed overdose, skin discolouration. MIRTAZAPINE dosage: 30 MG, DAILY (1/D). During the same period patient was treated with ZYPREXA, DIAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5345739-9
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 22, 2007. Female patient, 65 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: rheumatoid arthritis. MIRTAZAPINE dosage: 45 MG; ORAL. During the same period patient was treated with LEVOTHYROXINE, METHOTREXATE, OMEPRAZOLE, TRAMADOL. Patient recovered.
Mirtazapine Side Effects Report #5345744-2
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 22, 2007. Male patient, 64 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation, glycosylated haemoglobin increased. MIRTAZAPINE dosage: 15 MG/45 MG; ORAL. During the same period patient was treated with NIFEDIPINE, ALLOPURINOL, ATENOLOL, ATORVASTATIN CALCIUM, CLOPIDOGREL, DOXAZOSIN MESYLATE, FUROSEMIDE. Patient recovered.
Mirtazapine Side Effects Report #5347011-X
MIRTAZAPINE problem was reported by a Consumer or non-health professional from AUSTRALIA on May 22, 2007. Male patient, 84 years of age, was diagnosed with depression, tension and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, angina pectoris, angiopathy, aortic disorder, arthralgia, chronic obstructive pulmonary disease, confusional state, dizziness. MIRTAZAPINE dosage: 30 MG QD ORAL. During the same period patient was treated with EPROSARTAN MESILATE, VITAMIN A, ACETYLSALICYLIC ACID SRT. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5347024-8
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on May 29, 2007. Male patient, 34 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, antiphospholipid antibodies positive, cardiac disorder, coma, confusional state, dialysis, dissociation, disturbance in attention, factor v deficiency. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ANACAPS. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5347026-1
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SPAIN on May 29, 2007. Female patient, 75 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hepatitis. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with DEXAMETHASONE, OMEPRAZOLE, DIGOXIN, PHENYTOIN, FUROSEMIDE. Patient died.
Mirtazapine Side Effects Report #5354619-4
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 29, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, visual brightness, visual disturbance. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LOPERAMIDE, PREDNISOLONE, MERCAPTOPURINE, CARBOMER, ALENDRONIC ACID, IBUPROFEN. Patient recovered.
Mirtazapine Side Effects Report #5355187-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on May 30, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, visual brightness, visual disturbance. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, IBUPROFEN, LOPERAMIDE HYDROCHLORIDE, MERCAPTOPURINE, PREDNISOLONE, CARBOMER. Patient recovered.
Mirtazapine Side Effects Report #5355189-7
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on May 24, 2007. Male patient, 30 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: supraventricular tachycardia. MIRTAZAPINE dosage: 600 MG ONCE ORAL. During the same period patient was treated with ACETAMINOPHEN, ALCOHOL. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5362059-7
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Apr 13, 2007. Male patient, 75 years of age, was diagnosed with depression, sleep disorder and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: purpura, rash pruritic. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ALLOPURINOL, ASPIRIN, BISOPROLOL FUMARATE, BUMETANIDE, CLOPIDOGREL, LEVOTHYROXINE, SIMVASTATIN. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5362062-7
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on Apr 24, 2007. Female patient, 68 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: subarachnoid haemorrhage. MIRTAZAPINE dosage: unknown. During the same period patient was treated with DULOXETINE, TEMAZEPAM. Patient died.
Mirtazapine Side Effects Report #5362067-6
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 01, 2007. Female patient, 44 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, pelvic pain, urinary retention, urinary tract infection. MIRTAZAPINE dosage: unknown. During the same period patient was treated with PROMETHAZINE, FOLIC ACID, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5362868-4
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 12, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: agitation, akathisia, visual brightness. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ALENDRONIC ACID, IBUPROFEN, LOPERAMIDE HYDROCHLORIDE, MERCAPTOPURINE, PREDNISOLONE, VISCOTEARS. Patient recovered.
Mirtazapine Side Effects Report #5362870-2
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 07, 2007. Female patient, 16 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: shared psychotic disorder. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with LORAZEPAM. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5364297-6
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 07, 2007. Female patient, 16 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: psychotic disorder. MIRTAZAPINE dosage: 30 MG; QD; PO. During the same period patient was treated with ARIPIPRAZOLE, RISPERIDONE, OLANZAPINE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5367411-1
MIRTAZAPINE problem was reported by a Health Professional from SWEDEN on June 11, 2007. Male patient, 38 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety, completed suicide, insomnia. MIRTAZAPINE dosage: 30 MG;QD;PO. During the same period patient was treated with IBUPROFEN, PARACETAMOL, ZOPICLONE. Patient died.
Mirtazapine Side Effects Report #5368371-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 07, 2007. Female patient, 54 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: ageusia, anosmia, hot flush. MIRTAZAPINE dosage: 30 MG ORAL. During the same period patient was treated with ATORVASTATIN, BISOPROLOL, CLOPIDOGREL, CODEINE PHOSPHATE, EZETIMIBE, FUROSEMIDE, OMEPRAZOLE, RAMIPRIL. Patient recovered.
Mirtazapine Side Effects Report #5368551-3
MIRTAZAPINE problem was reported by a Physician from SWITZERLAND on June 04, 2007. Male patient, 27 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: obsessive-compulsive disorder. MIRTAZAPINE dosage: 30 MG. During the same period patient was treated with METHADONE, CITALOPRAM HYDROBROMIDE. Patient recovered.
Mirtazapine Side Effects Report #5369880-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 14, 2007. Male patient, 58 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: dyskinesia, dystonia, tardive dyskinesia. MIRTAZAPINE dosage: 45 MG, QD, ORAL. During the same period patient was treated with DEPAKOTE, OLANZAPINE, PROPRANOLOL, QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5369954-3
MIRTAZAPINE problem was reported by a Physician from UNITED KINGDOM on June 15, 2007. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: completed suicide, injury asphyxiation. MIRTAZAPINE dosage: unknown. Patient died.
Mirtazapine Side Effects Report #5371346-8
Consumer or non-health professional from NORWAY reported MIRTAZAPINE problem on May 03, 2007. Female patient, 66 years of age, was diagnosed with depression, insomnia, anxiety, pain and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: blister, pain in extremity, peroneal nerve palsy, skin ulcer. MIRTAZAPINE dosage: 15 MG QD ORAL. During the same period patient was treated with PREGABALIN. Patient recovered.
Mirtazapine Side Effects Report #5371849-6
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 14, 2007. Male patient, 58 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: dystonia, tardive dyskinesia. MIRTAZAPINE dosage: 45 MG; QD; PO. During the same period patient was treated with OLANZAPINE, QUETIAPINE, PROPRANOLOL, VALPROATE. Patient recovered.
Mirtazapine Side Effects Report #5372033-2
Consumer or non-health professional from BELGIUM reported MIRTAZAPINE problem on June 19, 2007. Female patient, 97 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anisochromia, blood lactate dehydrogenase increased, blood potassium increased, body temperature decreased, haematocrit decreased, haemoglobin decreased, hypochromasia, mean cell haemoglobin concentration decreased, mean cell haemoglobin decreased. MIRTAZAPINE dosage: 15 MG QD ORAL. During the same period patient was treated with RISPERIDONE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient died.
Mirtazapine Side Effects Report #5372861-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 13, 2007. Female patient, 37 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aggression, hallucination, auditory, hallucination, visual, jealous delusion, psychotic disorder, tremor. MIRTAZAPINE dosage: 45 MG. During the same period patient was treated with AMANTADINE, FUROSOMIDE, TIZANIDINE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5372871-6
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 14, 2007. Male patient, 58 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: dystonia, tardive dyskinesia, tongue paralysis. MIRTAZAPINE dosage: 45 MG (1X1),ORAL. During the same period patient was treated with DEPAKOTE, OLANZAPINE, PROPRANOLOL, QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5375898-3
MIRTAZAPINE problem was reported by a Pharmacist from UNITED STATES on June 27, 2007. Male patient, 55 years of age, was diagnosed with affective disorder and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: anxiety. MIRTAZAPINE dosage: 7.5MG EVERY DAY PO. Patient recovered.
Mirtazapine Side Effects Report #5377842-1
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 25, 2007. Male patient, 41 years of age, was diagnosed with anxiety, depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: adjustment disorder, depression, injury, intentional self-injury, neck injury, paranoia, personality disorder. MIRTAZAPINE dosage: DF/45 MG, ORAL. During the same period patient was treated with QUETIAPINE, VENLAFAXINE, VITAMIN CAP, MOVICOL. Patient recovered.
Mirtazapine Side Effects Report #5377843-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 19, 2007. Female patient, 44 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hydronephrosis, urinary tract infection. MIRTAZAPINE dosage: unknown. During the same period patient was treated with PROMETHAZINE, FOLIC ACID, OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5377846-9
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 25, 2007. Female patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: caesarean section, failed forceps delivery, hyponatraemia, pneumothorax. MIRTAZAPINE dosage: 15 MG QD, TRANSPLACENTAL. Patient recovered.
Mirtazapine Side Effects Report #5043324-X
MIRTAZAPINE problem was reported by a Pharmacist from UNITED STATES on July 03, 2006. Male patient, 56 years of age, weighting 276.9 lb, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: dry mouth. MIRTAZAPINE dosage: unknown. During the same period patient was treated with CHLORTHALIDONE, ASPIRIN, VARDENAFIL, OXYCODONE, RANITIDINE, SIMVASTATIN, ACETAMINOPHEN, GABAPENTIN. Patient recovered.
Mirtazapine Side Effects Report #5047148-9
Health Professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 21, 2006. Female patient, 45 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bruxism, trismus. MIRTAZAPINE dosage: 45 MG/60 MG. During the same period patient was treated with GABAPENTIN, METOCLOPRAMIDE, CLONAZEPAM. Patient recovered.
Mirtazapine Side Effects Report #5047259-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 21, 2006. Female patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: renal tubular necrosis. MIRTAZAPINE dosage: unknown. During the same period patient was treated with VENLAFAXINE, OLANZAPINE, NIMESULIDE. Patient recovered.
Mirtazapine Side Effects Report #5047273-2
Consumer or non-health professional from FRANCE reported MIRTAZAPINE problem on June 26, 2006. Male patient, 80 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epistaxis, thrombocytopenia. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LORAZEPAM, CYAMEMAZINE, LEVOTHYROXINE, ZOPICLONE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5049306-6
MIRTAZAPINE problem was reported by a Health Professional from SWITZERLAND on June 23, 2006. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: malaise, syncope. MIRTAZAPINE dosage: unknown. During the same period patient was treated with METHADONE, EFAVIRENZ, TENOFOVIR DISOPROXIL FUMARATE, LAMIVUDINE, BACTRIM DS. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5049623-X
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on June 22, 2006. Male patient, 59 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrioventricular block first degree, sinus bradycardia. MIRTAZAPINE dosage: unknown. Patient recovered.
Mirtazapine Side Effects Report #5050397-7
MIRTAZAPINE problem was reported by a Consumer or non-health professional from CANADA on June 26, 2006. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: pain in extremity, sleep disorder. MIRTAZAPINE dosage: 30 MG. Patient recovered.
Mirtazapine Side Effects Report #5050398-9
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on June 26, 2006. Male patient, 45 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: headache, muscular weakness, obstruction, sensory disturbance, serotonin syndrome, sinus tachycardia, vertigo, visual disturbance. MIRTAZAPINE dosage: 15 MG/30 MG/45 MG. During the same period patient was treated with SETRALINE, VENLAFAXINE, PROMETHAZINE, ACETYLSALICYLIC ACID SRT. Patient recovered.
Mirtazapine Side Effects Report #5050399-0
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 27, 2006. Female patient, 28 years of age, was diagnosed with anxiety, depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy, loss of consciousness. MIRTAZAPINE dosage: 45 MG. During the same period patient was treated with ACAMPROSATE, DISULPIRAM, CHLORDIAZEPOXIDE, ESCITALOPRAM OXALATE. Patient recovered.
Mirtazapine Side Effects Report #5050400-4
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on June 26, 2006. Male patient, 63 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, atrial flutter, chest pain, dyspnoea exertional. MIRTAZAPINE dosage: 7.5 MG/30 MG/45 MG. During the same period patient was treated with ZOLPIDEM TARTRATE, DIAZEPAM. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5051295-5
MIRTAZAPINE problem was reported by a Health Professional from SWITZERLAND on June 28, 2006. Female patient, 44 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: hepatocellular damage, ultrasound biliary tract abnormal. MIRTAZAPINE dosage: 30 MG QD ORAL. During the same period patient was treated with ESCITALOPRAM, ZOLPIDEM TARTRATE, CODEINE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5051441-3
Consumer or non-health professional from UNITED STATES reported MIRTAZAPINE problem on June 25, 2006. Male patient, 72 years of age, was diagnosed with major depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, confusional state, delirium, hyponatraemia, somnolence. MIRTAZAPINE dosage: 7.5 MG DAILY ORAL, USED FOR 5 DAYS. During the same period patient was treated with ATENOLOL, CHOLESTYRAMINE, ACETAMINOPHEN, PROCHLORPERAZINE, INSULIN, ALBUTEROL SPIROS, LISINOPRIL, VANCOMYCIN. Patient recovered.
Mirtazapine Side Effects Report #5051644-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2006. Male patient, 72 years of age, was diagnosed with major depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, confusional state, delirium, hyponatraemia, somnolence. MIRTAZAPINE dosage: 7.5 MG DAILY ORAL, USED FOR 5 DAYS. During the same period patient was treated with ATENOLOL, CHOLESTYRAMINE, ACETAMINOPHEN, PROCHLORPERAZINE, INSULIN, ALBUTEROL SPIROS, LISINOPRIL, VANCOMYCIN. Patient recovered.
Mirtazapine Side Effects Report #5053970-5
Physician from GERMANY reported MIRTAZAPINE problem on June 26, 2006. Female patient, 47 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: thrombophlebitis, venous thrombosis limb. MIRTAZAPINE dosage: 60 MG ORAL. During the same period patient was treated with VENLAFAXINE, PANTOPRAZOLE, METAMIZOLE MONOHYDRATE, IBUPROFEN. Patient recovered.
Mirtazapine Side Effects Report #5055161-0
MIRTAZAPINE problem was reported by a Consumer or non-health professional from THAILAND on July 08, 2006. Male patient, 41 years of age, was diagnosed with depression, headache, pain and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: coma, dyspnoea, haemodialysis, hepatic failure, hypersomnia, miosis, renal failure acute, stress. MIRTAZAPINE dosage: 1800 MG ORAL. During the same period patient was treated with AMOBARBITAL, CHLORPROMAZINE, ACETAMINOPHEN, MIDZOLAM, ALPRAZOLAM. Patient was hospitalized and became disabled. Patient recovered.
Mirtazapine Side Effects Report #5056229-5
Consumer or non-health professional from GERMANY reported MIRTAZAPINE problem on July 14, 2006. Male patient, 38 years of age, was diagnosed with depression, lung infection and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: akathisia, dementia, hyponatraemia. MIRTAZAPINE dosage: 15 MG. Patient recovered.
Mirtazapine Side Effects Report #5056230-1
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on July 09, 2006. Male patient, 95 years of age, was diagnosed with insomnia and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: aggression, agitation, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood magnesium decreased, blood potassium decreased, blood thyroid stimulating hormone decreased, blood urea increased. MIRTAZAPINE dosage: 15 MG. During the same period patient was treated with PIPAMPERONE, QUETIAPINE FUMARATE, QUETIAPINE FUMARATE, CLOMETHIAZOLE. Patient died.
Mirtazapine Side Effects Report #5057044-9
Health Professional from FRANCE reported MIRTAZAPINE problem on July 06, 2006. Female patient, 92 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cytolytic hepatitis, jaundice cholestatic. MIRTAZAPINE dosage: unknown. During the same period patient was treated with BISOPROLOL FUMARATE, FUROSEMIDE, FLUINDIONE, POTASSIUM CHLORIDE, ASPIRIN, AMPHOTERICIN B, OXYGEN. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5059432-3
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on July 06, 2006. Female patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: unknown. During the same period patient was treated with ESCITALOPRAM. Patient recovered.
Mirtazapine Side Effects Report #5059434-7
Consumer or non-health professional from SWITZERLAND reported MIRTAZAPINE problem on July 06, 2006. Male patient was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: epilepsy. MIRTAZAPINE dosage: unknown. Patient recovered.
Mirtazapine Side Effects Report #5060117-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from SWITZERLAND on July 07, 2006. Male patient, 17 years of age, was diagnosed with depression, disease recurrence, antisocial behaviour, delirium, extrapyramidal disorder, movement disorder and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: delirium, extrapyramidal disorder, loss of consciousness, suicidal ideation, tension. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, CITALOPRAM HYDROBROMIDE, LEVOMEPROMAZINE MALEATE, CLOMETHIAZOLE EDISILATE, BIPERIDEN HYDROCHLORIDE, BIPERIDEN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5060119-1
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 10, 2006. Male patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: cleft palate. MIRTAZAPINE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5060120-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on July 12, 2006. Female patient was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: muscle twitching, pallor, restlessness, syncope. MIRTAZAPINE dosage: unknown. During the same period patient was treated with QUETIAPINE FUMARATE. Patient recovered.
Mirtazapine Side Effects Report #5062455-1
Consumer or non-health professional from THAILAND reported MIRTAZAPINE problem on July 08, 2006. Male patient, 40 years of age, was diagnosed with depression, oral contraception, headache, pain and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: coma, completed suicide, face oedema, haemodialysis, hepatic failure, loss of consciousness, miosis, oedema peripheral. MIRTAZAPINE dosage: /1800 MG ORAL. During the same period patient was treated with AMOBARBITAL, CHLORPROMAZINE, ACETAMINOPHEN, MIDAZOLAM HYDROCHLORIDE, ALPRAZOLAM. Patient was hospitalized and became disabled. Patient recovered.
Mirtazapine Side Effects Report #5062459-9
MIRTAZAPINE problem was reported by a Consumer or non-health professional from FRANCE on July 12, 2006. Female patient, 90 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: apathy, blood glucose decreased, blood pressure systolic increased, bradycardia, coma, hypotension, pallor, red blood cell sedimentation rate increased. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with OMEPRAZOLE, NICARDIPINE HYDROCHLORIDE, FUROSEMIDE, ASPIRIN. Patient recovered.
Mirtazapine Side Effects Report #5065416-1
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 10, 2006. Male patient, 72 years of age, was diagnosed with dementia and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: haematuria, thrombocytopenia. MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with ASPIRIN, SIMVASTATINLET. Patient recovered.
Mirtazapine Side Effects Report #5065823-7
MIRTAZAPINE problem was reported by a Consumer or non-health professional from GERMANY on July 19, 2006. Male patient, 38 years of age, was diagnosed with depression, lung infection and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: akathisia, confusional state, hyponatraemia. MIRTAZAPINE dosage: 15 MG. Patient recovered.
Mirtazapine Side Effects Report #5065913-9
Health Professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 27, 2006. Female patient, 34 years of age, was diagnosed with schizophrenia and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiotoxicity, eosinophilia, hypersensitivity, type ii hypersensitivity. MIRTAZAPINE dosage: unknown. During the same period patient was treated with TEMAZEPAM, CLOZAPINE. Patient died on 01/01/2006.
Mirtazapine Side Effects Report #5066094-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 13, 2006. Female patient, 22 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: convulsion, serotonin syndrome. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LINEZOLID. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5066095-X
Consumer or non-health professional from UNITED STATES reported MIRTAZAPINE problem on July 13, 2006. Male patient, 39 years of age, was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: serotonin syndrome. MIRTAZAPINE dosage: unknown. During the same period patient was treated with LINEZOLID. Patient recovered.
Mirtazapine Side Effects Report #5066147-4
MIRTAZAPINE problem was reported by a Health Professional from UNITED KINGDOM on July 18, 2006. Male patient, 76 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: depression, homicidal ideation, suicidal ideation. MIRTAZAPINE dosage: 15 MG ORAL. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5066928-7
Consumer or non-health professional from UNITED KINGDOM reported MIRTAZAPINE problem on July 15, 2006. Female patient, 44 years of age, was diagnosed with depression and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased. MIRTAZAPINE dosage: 30 MG, ORAL. During the same period patient was treated with RISPERIDONE, ESCITALOPRAM, DOXORUBICIN, CYCLOPHOSPHAMIDE, METROTREXATE, FLUOROURACIL. Patient recovered.
Mirtazapine Side Effects Report #5069974-2
MIRTAZAPINE problem was reported by a Consumer or non-health professional from GERMANY on July 25, 2006. Female patient, 75 years of age, was diagnosed with depression, hyperthyroidism and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: bone marrow toxicity, cerebral infarction, leukopenia, pain, sepsis. MIRTAZAPINE dosage: unknown. During the same period patient was treated with THIAMAZOLE. Patient died.
Mirtazapine Side Effects Report #5069975-4
Consumer or non-health professional from AUSTRALIA reported MIRTAZAPINE problem on July 20, 2006. Female patient, 79 years of age, was diagnosed with depression, essential hypertension and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dizziness, hypokalaemia, hyponatraemia, nausea. MIRTAZAPINE dosage: 30 MG/15 MG,ORAL. During the same period patient was treated with FUROSEMIDE, INDAPAMIDE, PANTOPRAZOLE, VALPROATE, ALENDRONATE, ERGOCALCIFEROL, MOVICOL, MORPHINE SULPHATE. Patient was hospitalized. Patient recovered.
Mirtazapine Side Effects Report #5069980-8
MIRTAZAPINE problem was reported by a Consumer or non-health professional from NETHERLANDS on July 25, 2006. Female patient, 39 years of age, was diagnosed with depression, contraception and was treated with MIRTAZAPINE. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. MIRTAZAPINE dosage: 15 MG. During the same period patient was treated with DIANE. Patient recovered.
< Previous Showing 201-300 of 574 Next >
Drug Information: Mirtazapine
URL of this page: http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a697009.html
(mir taz' a peen)IMPORTANT WARNING:
| A small number of children, teenagers, and young adults (up to 24 years of age) who took antidepressants ('mood elevators') such as mirtazapine during clinical studies became suicidal (thinking about harming or killing oneself or planning or trying to do so). Children, teenagers, and young adults who take antidepressants to treat depression or other mental illnesses may be more likely to become suicidal than children, teenagers, and young adults who do not take antidepressants to treat these conditions. However, experts are not sure about how great this risk is and how much it should be considered in deciding whether a child or teenager should take an antidepressant. Children younger than 18 years of age should not normally take mirtazapine, but in some cases, a doctor may decide that mirtazapine is the best medication to treat a child's condition.You should know that your mental health may change in unexpected ways when you take mirtazapine or other antidepressants even if you are an adult over age 24. You may become suicidal, especially at the beginning of your treatment and any time that your dose is increased or decreased. You, your family, or your caregiver should call your doctor right away if you experience any of the following symptoms: new or worsening depression; thinking about harming or killing yourself, or planning or trying to do so; extreme worry; agitation; panic attacks; difficulty falling asleep or staying asleep; aggressive behavior; irritability; acting without thinking; severe restlessness; and frenzied abnormal excitement. Be sure that your family or caregiver knows which symptoms may be serious so they can call the doctor when you are unable to seek treatment on your own.Your healthcare provider will want to see you often while you are taking mirtazapine, especially at the beginning of your treatment. Be sure to keep all appointments for office visits with your doctor.The doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with mirtazapine. Read the information carefully and ask your doctor or pharmacist if you have any questions. You also can obtain the Medication Guide from the FDA website: http://www.fda.gov/cder/drug/antidepressants/antidepressants_MG_2007.pdf.No matter what your age, before you take an antidepressant, you, your parent, or your caregiver should talk to your doctor about the risks and benefits of treating your condition with an antidepressant or with other treatments. You should also talk about the risks and benefits of not treating your condition. You should know that having depression or another mental illness greatly increases the risk that you will become suicidal. This risk is higher if you or anyone in your family has or has ever had bipolar disorder (mood that changes from depressed to abnormally excited) or mania (frenzied, abnormally excited mood) or has thought about or attempted suicide. Talk to your doctor about your condition, symptoms, and personal and family medical history. You and your doctor will decide what type of treatment is right for you. |
Why is this medication prescribed?
Mirtazapine is used to treat depression. Mirtazapine is in a class of medications called antidepressants. It works by increasing certain types of activity in the brain to maintain mental balance.
How should this medicine be used?
Mirtazapine comes as a tablet and as a disintegrating tablet to take by mouth. It usually is taken once a day at bedtime. It may be taken with or without food. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take mirtazapine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
To take a mirtazapine disintegrating tablet, open the blister pack with dry hands and place the tablet on your tongue. The tablet will disintegrate on the tongue and can be swallowed with saliva. No water is needed to swallow disintegrating tablets. Once the tablet is removed from the blister pack, it cannot be stored. Do not split mirtazapine disintegrating tablets.
It may take several weeks or longer for you to feel the full benefit of mirtazapine. Continue to take mirtazapine even if you feel well. Do not stop taking mirtazapine without talking to your doctor. Your doctor probably will decrease your dose gradually.
Other uses for this medicine
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
What special precautions should I follow?
Before taking mirtazapine,
- tell your doctor and pharmacist if you are allergic to mirtazapine or any other medications.
- tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to tell the doctor if you are taking diazepam (Valium) and if you are taking an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam, Zelapar), and tranylcypromine (Parnate) or if you have stopped taking an MAO inhibitor within the past 14 days. Your doctor may tell you not to take mirtazapine.
- tell your doctor if you have or have ever had a heart attack, low blood pressure, heart or liver disease, or high cholesterol.
- tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking mirtazapine, call your doctor.
- if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking mirtazapine.
- you should know that this medication may make you drowsy. Do not drive a car or operate machinery until you know how this medication affects you.
- remember that alcohol can add to the drowsiness caused by this medication.
- if you have phenylketonuria (PKU, a inherited condition in which a special diet must be followed to prevent mental retardation), you should know that the orally disintegrating tablets contain phenylalanine.
What special dietary instructions should I follow?
Unless your doctor tells you otherwise, continue your normal diet.
What should I do if I forget a dose?
Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.
What side effects can this medication cause?
Mirtazapine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- drowsiness
- dizziness
- anxiousness
- confusion
- increased weight and appetite
- dry mouth
- constipation
- nausea
- vomiting
Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:
- flu-like symptoms, fever, chills, sore throat, mouth sores, or other signs of infection
- chest pain
- fast heartbeat
- seizures
Mirtazapine may cause other side effects. Call your doctor if you have any unusual problems while you are taking this medication.
If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online [at http://www.fda.gov/MedWatch/index.html] or by phone [1-800-332-1088].
What storage conditions are needed for this medicine?
Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom). Throw away any medication that is outdated or no longer needed. Talk to your pharmacist about the proper disposal of your medication.
In case of emergency/overdose
In case of overdose, call your local poison control center at 1-800-222-1222. If the victim has collapsed or is not breathing, call local emergency services at 911.
What other information should I know?
Keep all appointments with your doctor and the laboratory. Your doctor may order certain lab tests to check your response to mirtazapine.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
Brand name(s):
|
|
Ask Our Patient Community about Mirtazapine |
||
|
|
||
|
|
||